Safety of Adalimumab in Pediatric Patients with Polyarticular Juvenile Idiopathic Arthritis, Enthesitis-Related Arthritis, Psoriasis, and Crohn's Disease [PDF]
Contains fulltext : 195625.pdf (Publisher’s version ) (Open Access)OBJECTIVE: To evaluate the safety of adalimumab in pediatric patients who participated in clinical trials of juvenile idiopathic arthritis (polyarticular juvenile ...
Arikan, D. +9 more
core +1 more source
Outcome of Juvenile Idiopathic Arthritis Associated Uveitis in Two Disease Subtypes
Objectives: This study aims to evaluate the efficacy of adalimumab as a first line biologic agent in specific subtypes of juvenile idiopathic arthritis (JIA) patients with associated uveitis. Patients and Methods: We retrospectively analyzed the data
Dragana LAZAREVIĆ +3 more
doaj
Inactive Disease in Enthesitis-related Arthritis: Association of Increased Body Mass Index
Objective. Patients with enthesitis-related arthritis (ERA) were less likely to achieve and sustain inactive disease than children with other subtypes of juvenile idiopathic arthritis.
Unsal, Erbil +2 more
core +1 more source
Axial involvement in enthesitis-related arthritis: results from a single-center cohort. [PDF]
Guo Y +6 more
europepmc +1 more source
Effectiveness of tumor necrosis factor inhibitors in children with enthesitis-related arthritis: a single-center retrospective analysis. [PDF]
Zhang T +10 more
europepmc +1 more source
Enthesitis-Related Arthritis in a Child with Turner Syndrome
Shruti Bajaj +2 more
doaj +1 more source
Counting the cost: the current and future burden of arthritis
A major new report shows the growing multi-billion dollar costs of arthritis to the economy, individuals and to the healthcare system and how relatively small investments could yield savings of more than $170 million a year.
Arthritis Australia
core
Background We evaluated the PEDSnet clinical research network for study enrollment of juvenile spondyloarthritis, a rare rheumatic disease that includes enthesitis-related arthritis (ERA) and psoriatic arthritis (PsA). Methods An electronic health record
Pamela F. Weiss +12 more
doaj +1 more source
Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial. [PDF]
Brunner HI +23 more
europepmc +1 more source
Introduction Synovitis and enthesitis are key manifestations in psoriatic arthritis (PsA). This descriptive analysis investigated the association between improvement in synovitis and enthesitis, individually and combined, and improvement in patient ...
Lars-Erik Kristensen +7 more
doaj +1 more source

